These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16876138)

  • 1. Metabotropic glutamate receptor antagonists: novel therapeutics for nicotine dependence and depression?
    Markou A
    Biol Psychiatry; 2007 Jan; 61(1):17-22. PubMed ID: 16876138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
    Liechti ME; Markou A
    Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats.
    Li X; D'Souza MS; Niño AM; Doherty J; Cross A; Markou A
    Psychopharmacology (Berl); 2016 May; 233(10):1801-14. PubMed ID: 26873083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic Glutamate Receptors 2 and 3 as Targets for Treating Nicotine Addiction.
    Cross AJ; Anthenelli R; Li X
    Biol Psychiatry; 2018 Jun; 83(11):947-954. PubMed ID: 29301614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking.
    Tessari M; Pilla M; Andreoli M; Hutcheson DM; Heidbreder CA
    Eur J Pharmacol; 2004 Sep; 499(1-2):121-33. PubMed ID: 15363959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
    Kenny PJ; Gasparini F; Markou A
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats.
    Paterson NE; Markou A
    Psychopharmacology (Berl); 2005 Apr; 179(1):255-61. PubMed ID: 15619120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation.
    Markou A; Paterson NE; Semenova S
    Ann N Y Acad Sci; 2004 Oct; 1025():491-503. PubMed ID: 15542754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant].
    Chaki S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):219-26. PubMed ID: 23012890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders.
    Spooren WP; Gasparini F; Salt TE; Kuhn R
    Trends Pharmacol Sci; 2001 Jul; 22(7):331-7. PubMed ID: 11431019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats.
    Bespalov AY; Dravolina OA; Sukhanov I; Zakharova E; Blokhina E; Zvartau E; Danysz W; van Heeke G; Markou A
    Neuropharmacology; 2005; 49 Suppl 1():167-78. PubMed ID: 16023685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabotropic glutamate 2/3 receptor activation induced reward deficits but did not aggravate brain reward deficits associated with spontaneous nicotine withdrawal in rats.
    Liechti ME; Markou A
    Biochem Pharmacol; 2007 Oct; 74(8):1299-307. PubMed ID: 17601493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction.
    Carroll FI
    Ann N Y Acad Sci; 2008 Oct; 1141():221-32. PubMed ID: 18991960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: review article.
    Kuhn R; Pagano A; Stoehr N; Vranesic I; Flor PJ; Lingenhöhl K; Spooren W; Gentsch C; Vassout A; Pilc A; Gasparini F
    Amino Acids; 2002; 23(1-3):207-11. PubMed ID: 12373539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies.
    Liechti ME; Markou A
    CNS Drugs; 2008; 22(9):705-24. PubMed ID: 18698872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats.
    Kenny PJ; Paterson NE; Boutrel B; Semenova S; Harrison AA; Gasparini F; Koob GF; Skoubis PD; Markou A
    Ann N Y Acad Sci; 2003 Nov; 1003():415-8. PubMed ID: 14684476
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice.
    Ago Y; Yano K; Araki R; Hiramatsu N; Kita Y; Kawasaki T; Onoe H; Chaki S; Nakazato A; Hashimoto H; Baba A; Takuma K; Matsuda T
    Neuropharmacology; 2013 Feb; 65():29-38. PubMed ID: 23022081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats.
    Dravolina OA; Zakharova ES; Shekunova EV; Zvartau EE; Danysz W; Bespalov AY
    Neuropharmacology; 2007 Feb; 52(2):263-9. PubMed ID: 16963088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 - present).
    Celanire S; Sebhat I; Wichmann J; Mayer S; Schann S; Gatti S
    Expert Opin Ther Pat; 2015 Jan; 25(1):69-90. PubMed ID: 25435285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of NMDA receptor antagonists in nicotine tolerance, sensitization, and physical dependence: a preclinical review.
    Jain R; Mukherjee K; Balhara YP
    Yonsei Med J; 2008 Apr; 49(2):175-88. PubMed ID: 18452252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.